News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
GSK Bio
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Rumored Pfizer Deal to Buy CRISPR for $1.64 Billion Could Lock in CRISPR and CAR T Tech
May 29, 2015
·
2 min read
Job Trends
Novartis AG to Eliminate Up to 110 U.S. Jobs Through Voluntary Retirement Offering
May 28, 2015
·
4 min read
Business
Pronutria Bags $39M for Research, Possible Staff Expansion and Recruits Two Ex-Vertex Execs
May 28, 2015
·
4 min read
Job Trends
Pfizer Will Lay Off 750 Workers at Pearl River Site in 2017, Inks New Land Deal
May 28, 2015
·
4 min read
Job Trends
Gilead Will Hire Up to 170 Scientists in $100 Million Edmonton Expansion
May 28, 2015
·
4 min read
Deals
Gilead’s Hep B Trial Failure Will Inspire M&A Activity, Say Analysts
May 28, 2015
·
7 min read
Drug Development
Investors Wait With Bated Breath for ImmunoGen’s Ovarian Cancer Drug ASCO News
May 28, 2015
·
3 min read
Deals
Teva Buys Stake in Mylan, As Takeover Attempt Turns Nasty
May 28, 2015
·
9 min read
Biotech Bay
BioSpace Temperature Poll: Will PfizerKline Become the Next Pharma Player?
May 27, 2015
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
May 28, 2025
·
9 min read
Press Releases
Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
November 12, 2024
·
4 min read
Press Releases
Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk
November 5, 2024
·
7 min read
Press Releases
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
October 8, 2024
·
10 min read
Pharm Country
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
March 7, 2024
·
5 min read
Pharm Country
GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies
August 17, 2023
·
6 min read
Deals
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
May 16, 2023
·
7 min read
Business
AnaptysBio- and GSK-partnered immuno-oncology agent JEMPERLI (dostarlimab-gxly) meets primary endpoint in Phase 3 RUBY trial in primary advanced or recurrent endometrial cancer
December 2, 2022
·
5 min read
